What Are the Common Issues Found During Chinese Drug Quality Audits?

Common issues in Chinese drug quality audits include inadequate documentation, non-compliance with Good Manufacturing Practices (GMP), insufficient staff training, poor quality control procedures, contamination risks, improper storage conditions, lack of traceability, and inconsistent batch records. These issues can compromise drug safety, efficacy, and regulatory compliance, necessitating corrective actions and continuous monitoring.

Leave a Reply

You must be logged in to post a comment.